BookJohn D. Ash, Christian Grimm, Joe G. Hollyfield, Robert E. Anderson, Matthew M. LaVail, Catherine Bowes Rickman, editors.
Summary: "This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the “best” and “most important” meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy."--Publisher's website.
Contents:
Part I. Basic processes: development, physiology and function
Part II. Basic processes: RPE
Part III. Basic processes: methodology
Part IV. Genetics in retinal disease
Part V. AMD: novel developments
Müller cells, microglia, and macrophages
Part VII. Degenerative processes: immune-related mechanisms, genes and factors
Part VII. Degenerative processes: RPE and fatty acids
Part IX. Degenerative processes: immune-related mechanisms, genes and factors
Part X. Therapy: gene therapy
Part XI. Therapy: protection
Index.
Location
Version
Call Number
Items